Gotowe bibliografie tematyczne / Pyrazolopyrimidines / Artykuły w czasopismach

Artykuły w czasopismach na temat „Pyrazolopyrimidines”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Pyrazolopyrimidines.
Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 20 lutego 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Pyrazolopyrimidines”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

George, CFP. "Pyrazolopyrimidines". Lancet 358, nr 9293 (listopad 2001): 1623–26. http://dx.doi.org/10.1016/s0140-6736(01)06656-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Wald, Jiri, Marion Pasin, Martina Richter, Christin Walther, Neann Mathai, Johannes Kirchmair, Vadim A. Makarov i in. "Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site". Proceedings of the National Academy of Sciences 116, nr 38 (28.08.2019): 19109–15. http://dx.doi.org/10.1073/pnas.1904732116.

Pełny tekst źródła
Streszczenie:
Viral inhibitors, such as pleconaril and vapendavir, target conserved regions in the capsids of rhinoviruses (RVs) and enteroviruses (EVs) by binding to a hydrophobic pocket in viral capsid protein 1 (VP1). In resistant RVs and EVs, bulky residues in this pocket prevent their binding. However, recently developed pyrazolopyrimidines inhibit pleconaril-resistant RVs and EVs, and computational modeling has suggested that they also bind to the hydrophobic pocket in VP1. We studied the mechanism of inhibition of pleconaril-resistant RVs using RV-B5 (1 of the 7 naturally pleconaril-resistant rhinoviruses) and OBR-5-340, a bioavailable pyrazolopyrimidine with proven in vivo activity, and determined the 3D-structure of the protein-ligand complex to 3.6 Å with cryoelectron microscopy. Our data indicate that, similar to other capsid binders, OBR-5-340 induces thermostability and inhibits viral adsorption and uncoating. However, we found that OBR-5-340 attaches closer to the entrance of the pocket than most other capsid binders, whose viral complexes have been studied so far, showing only marginal overlaps of the attachment sites. Comparing the experimentally determined 3D structure with the control, RV-B5 incubated with solvent only and determined to 3.2 Å, revealed no gross conformational changes upon OBR-5-340 binding. The pocket of the naturally OBR-5-340-resistant RV-A89 likewise incubated with OBR-5-340 and solved to 2.9 Å was empty. Pyrazolopyrimidines have a rigid molecular scaffold and may thus be less affected by a loss of entropy upon binding. They interact with less-conserved regions than known capsid binders. Overall, pyrazolopyrimidines could be more suitable for the development of new, broadly active inhibitors.
Style APA, Harvard, Vancouver, ISO itp.
3

Lu, Shi-Han, Po-Lin Liu i Fung Fuh Wong. "Vilsmeier reagent-mediated synthesis of 6-[(formyloxy)methyl]-pyrazolopyrimidines via a one-pot multiple tandem reaction". RSC Advances 5, nr 58 (2015): 47098–107. http://dx.doi.org/10.1039/c5ra07707a.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Agrebi, Asma, Fatma Allouche, Hamadi Fetoui i Fakher Chabchoub. "Synthesis and biological evaluation of new pyrazolo[3,4-d]pyrimidine derivatives". Mediterranean Journal of Chemistry 3, nr 2 (13.05.2014): 864. http://dx.doi.org/10.13171/mjc.3.2.2014.13.05.23agrebi.

Pełny tekst źródła
Streszczenie:
<p class="Default">Several new pyrazolopyrimidine compounds were achieved from aminocyanopyarazole <strong>1</strong>. The starting material <strong>1 </strong>was initially coupled with orthoester at refluxed with various primary amines, ammonia, hydrazines and hydroxylamine to furnish a series of pyrazolo[3,4-<em>d</em>]pyrimidines. The reaction of imidate <strong>2a-b </strong>with hydrazide derivatives led to the formation of pyrazolo[3,4-<em>d</em>][1,2,4]triazolo[4,3-<em>c</em>]pyrimidines. Some of the synthesized compounds <strong>3a </strong>and <strong>4c </strong>were evaluated for their anti-inflammatory, antipyretic and nociceptive activities. We start by studing the toxicity of these two molecules by measuring the corresponding DL50. The DL50 of <strong>3a </strong>and <strong>4c </strong>are estimated to 1333.2mg / kg and 1593.5mg / kg respectively. Pharmacological evaluation showed that compounds <strong>3a </strong>and <strong>4c </strong>at doses (5.5-22.2 mg / Kg, i.p) exhibited anti-inflammatory activities compared to Ibuprofen (150 mg / Kg, i.p), used as a refer ence drug. Further, our study showed that the injection of derived pyrazolopyrimidines on hyperthermic animal leads to a decrease in temperature after 1 hours of treatment compared to paracetamol used as reference. In addition, the injection of derived pyrazolopyrimidines at different doses contains a potent nociceptive activity. This effect is dose-dependent compared to aspirin.</p>
Style APA, Harvard, Vancouver, ISO itp.
5

Elnagdi, Mohamed Hilmy, Ahmed Hafiz Husein Elghandour, Mohamed Kamal Ahmed Ibrahim i Ibrahim Saad Abdel Hafiz. "Studies with Polyfunctionally Substituted Heterocycles: Synthesis of New Pyridines, Naphtho[1,2-b]pyrans, Pyrazolo[3,4-b]pyridines and Pyrazolo[l,5-a]pyrimidines". Zeitschrift für Naturforschung B 47, nr 4 (1.04.1992): 572–78. http://dx.doi.org/10.1515/znb-1992-0419.

Pełny tekst źródła
Streszczenie:
A variety of new polyfunctionally substituted pyridines, naphthopyrans and pyrazolopyrimidines were prepared via reacting ylidenemalononitriles with thiophenol, thionaphthol, naphthols and or aminopyrazoles.
Style APA, Harvard, Vancouver, ISO itp.
6

Kolosov, Maksim A., Dmitriy A. Beloborodov, Valeriy D. Orlov i Victor V. Dotsenko. "Catalyst-free Biginelli-type synthesis of new functionalized 4,7-dihydropyrazolo[1,5-a]pyrimidines". New Journal of Chemistry 40, nr 9 (2016): 7573–79. http://dx.doi.org/10.1039/c6nj00336b.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

El-Dean, Adel M. Kamal, i Maisa E. Abdel-Moneam. "Synthesis of Pyrimidines, Thienopyrimidines, and Pyrazolopyrimidines". Phosphorus, Sulfur, and Silicon and the Related Elements 177, nr 12 (1.12.2002): 2745–51. http://dx.doi.org/10.1080/10426500214894.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Weitensteiner, Sabine B., Johanna Liebl, Vladimir Krystof, Libor Havlíček, Tomáš Gucký, Miroslav Strnad, Robert Fürst, Angelika M. Vollmar i Stefan Zahler. "Trisubstituted Pyrazolopyrimidines as Novel Angiogenesis Inhibitors". PLoS ONE 8, nr 1 (15.01.2013): e54607. http://dx.doi.org/10.1371/journal.pone.0054607.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Rice, Kenneth D., Moon H. Kim, Joerg Bussenius, Neel K. Anand, Charles M. Blazey, Owen J. Bowles, Lynne Canne-Bannen i in. "Pyrazolopyrimidines as dual Akt/p70S6K inhibitors". Bioorganic & Medicinal Chemistry Letters 22, nr 8 (kwiecień 2012): 2693–97. http://dx.doi.org/10.1016/j.bmcl.2012.03.011.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Ahmed, Sayed A., Ahmed M. Hussein, Walaa G. M. Hozayen, Ahmed H. H. El-Ghandour i Abdou O. Abdelhamid. "Synthesis of some pyrazolopyrimidines as purine analogues". Journal of Heterocyclic Chemistry 44, nr 4 (lipiec 2007): 803–10. http://dx.doi.org/10.1002/jhet.5570440408.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
11

Kumar, Hansal, Rudradip Das, Asmita Choithramani, Astha Gupta, Datta Khude, Gourav Bothra i Amit Shard. "Efficient Green Protocols for the Preparation of Pyrazolopyrimidines". ChemistrySelect 6, nr 23 (18.06.2021): 5807–37. http://dx.doi.org/10.1002/slct.202101298.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Looker, D. L., J. J. Marr i R. L. Berens. "Mechanisms of action of pyrazolopyrimidines in Leishmania donovani." Journal of Biological Chemistry 261, nr 20 (lipiec 1986): 9412–15. http://dx.doi.org/10.1016/s0021-9258(18)67670-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Gudmundsson, Kristjan S., Brian A. Johns i Jason Weatherhead. "Pyrazolopyrimidines and pyrazolotriazines with potent activity against herpesviruses". Bioorganic & Medicinal Chemistry Letters 19, nr 19 (październik 2009): 5689–92. http://dx.doi.org/10.1016/j.bmcl.2009.08.009.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Di Grandi, Martin J., Dan M. Berger, Darrin W. Hopper, Chunchun Zhang, Minu Dutia, Alejandro L. Dunnick, Nancy Torres i in. "Novel pyrazolopyrimidines as highly potent B-Raf inhibitors". Bioorganic & Medicinal Chemistry Letters 19, nr 24 (grudzień 2009): 6957–61. http://dx.doi.org/10.1016/j.bmcl.2009.10.058.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

M. Kamal El-Dean, Adel, i Ahmed A. Geies. "Synthesis of Some New Pyrazolotriazines, Pyrazolothiazines and Pyrazolopyrimidines". Journal of Chemical Research, nr 10 (1997): 352. http://dx.doi.org/10.1039/a702058i.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Azimioara, Mihai, Phil Alper, Christopher Cow, Daniel Mutnick, Victor Nikulin, Gerald Lelais, John Mecom i in. "Novel tricyclic pyrazolopyrimidines as potent and selective GPR119 agonists". Bioorganic & Medicinal Chemistry Letters 24, nr 23 (grudzień 2014): 5478–83. http://dx.doi.org/10.1016/j.bmcl.2014.10.010.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Osuma, Augustine T., Xiangdong Xu, Zhi Wang, Jennifer A. Van Camp i Gail M. Freiberg. "Design and evaluation of pyrazolopyrimidines as KCNQ channel modulators". Bioorganic & Medicinal Chemistry Letters 29, nr 19 (październik 2019): 126603. http://dx.doi.org/10.1016/j.bmcl.2019.08.007.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
18

Shamroukh, Ahmed H., Aymn E. Rashad, Hatem S. Ali i Farouk M. E. Abdel-Megeid. "Some New Pyrazole and Pyrazolopyrimidines: Synthesis and Antimicrobial Evaluation". Journal of Heterocyclic Chemistry 50, nr 4 (24.06.2013): 758–65. http://dx.doi.org/10.1002/jhet.1550.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
19

Rashad, Aymn E., Mohamed Abdelmegid, Ahmed H. Shamroukh i Farouk M. E. Abdelmegeid. "ChemInform Abstract: The Chemistry of Pyrazolopyrimidines and Their Applications". ChemInform 45, nr 52 (11.12.2014): no. http://dx.doi.org/10.1002/chin.201452265.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Ahmed, Sayed A., Hussein S. Elgendy i Walaa O. Younis. "ChemInform Abstract: Pyrazolopyrimidines: Synthesis, Chemical Reactions and Biological Activity". ChemInform 46, nr 14 (19.03.2015): no. http://dx.doi.org/10.1002/chin.201514291.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
21

Gu, Yun-Qiong, Wen-Ying Shen, Qi-Yuan Yang, Zhen-Feng Chen i Hong Liang. "Ru(iii) complexes with pyrazolopyrimidines as anticancer agents: bioactivities and the underlying mechanisms". Dalton Transactions 51, nr 4 (2022): 1333–43. http://dx.doi.org/10.1039/d1dt02765d.

Pełny tekst źródła
Streszczenie:
Ruthenium(III) complex with pyrazolopyrimidine inhibited tumor cells proliferation, caused DNA damage by interacting with DNA and inhibition of the Topo I enzyme, induced cell cycle arrest in S phase and apoptosis via mitochondrial dysfunction.
Style APA, Harvard, Vancouver, ISO itp.
22

El-Naggar, Mohamed, Ashraf Hassan, Hanem Awad i Mohamed Mady. "Design, Synthesis and Antitumor Evaluation of Novel Pyrazolopyrimidines and Pyrazoloquinazolines". Molecules 23, nr 6 (23.05.2018): 1249. http://dx.doi.org/10.3390/molecules23061249.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

Goshu, Gashaw M., Debarati Ghose, Joy M. Bain, Phillip G. Pierce, Darren W. Begley, Stephen N. Hewitt, Hannah S. Udell, Peter J. Myler, R. Meganathan i Timothy J. Hagen. "Synthesis and biological evaluation of pyrazolopyrimidines as potential antibacterial agents". Bioorganic & Medicinal Chemistry Letters 25, nr 24 (grudzień 2015): 5699–704. http://dx.doi.org/10.1016/j.bmcl.2015.10.096.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
24

Makarov, Vadim A., Heike Braun, Martina Richter, Olga B. Riabova, Johannes Kirchmair, Elena S. Kazakova, Nora Seidel, Peter Wutzler i Michaela Schmidtke. "Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses". ChemMedChem 10, nr 10 (10.08.2015): 1629–34. http://dx.doi.org/10.1002/cmdc.201500304.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
25

Hassan, Ghaneya S., Doaa E. Abdel Rahman, Yassin M. Nissan, Esraa A. Abdelmajeed i Tamer M. Abdelghany. "Novel pyrazolopyrimidines: Synthesis, in vitro cytotoxic activity and mechanistic investigation". European Journal of Medicinal Chemistry 138 (wrzesień 2017): 565–76. http://dx.doi.org/10.1016/j.ejmech.2017.07.003.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

EL-DEAN, A. M. K., i A. A. GEIES. "ChemInform Abstract: Synthesis of Some New Pyrazolotriazines, Pyrazolothiazines and Pyrazolopyrimidines". ChemInform 29, nr 8 (23.06.2010): no. http://dx.doi.org/10.1002/chin.199808034.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

C. S. Pinheiro, Luiz, Lívia M. Feitosa, Marilia O. Gandi, Flávia F. Silveira i Nubia Boechat. "The Development of Novel Compounds Against Malaria: Quinolines, Triazolpyridines, Pyrazolopyridines and Pyrazolopyrimidines". Molecules 24, nr 22 (13.11.2019): 4095. http://dx.doi.org/10.3390/molecules24224095.

Pełny tekst źródła
Streszczenie:
Based on medicinal chemistry tools, new compounds for malaria treatment were designed. The scaffolds of the drugs used to treat malaria, such as chloroquine, primaquine, amodiaquine, mefloquine and sulfadoxine, were used as inspiration. We demonstrated the importance of quinoline and non-quinoline derivatives in vitro with activity against the W2 chloroquine-resistant (CQR) Plasmodium falciparum clone strain and in vivo against Plasmodium berghei-infected mouse model. Among the quinoline derivatives, new hybrids between chloroquine and sulfadoxine were designed, which gave rise to an important prototype that was more active than both chloroquine and sulfadoxine. Hybrids between chloroquine–atorvastatin and primaquine–atorvastatin were also synthesized and shown to be more potent than the parent drugs alone. Additionally, among the quinoline derivatives, new mefloquine derivatives were synthesized. Among the non-quinoline derivatives, we obtained excellent results with the triazolopyrimidine nucleus, which gave us prototype I that inspired the synthesis of new heterocycles. The pyrazolopyrimidine derivatives stood out as non-quinoline derivatives that are potent inhibitors of the P. falciparum dihydroorotate dehydrogenase (PfDHODH) enzyme. We also examined the pyrazolopyridine and pyrazolopyrimidine nuclei.
Style APA, Harvard, Vancouver, ISO itp.
28

Colombo, Raffaele, Kyu Ok Jeon, Donna M. Huryn, Matthew G. LaPorte i Peter Wipf. "A New Synthesis of 4,5,6,7-Tetrahydropyrazolo[1,5-c]pyrimidines by a Retro-Mannich Cascade Rearrangement". Australian Journal of Chemistry 67, nr 3 (2014): 420. http://dx.doi.org/10.1071/ch13468.

Pełny tekst źródła
Streszczenie:
We discovered a new retro-Mannich reaction of in situ prepared pyrazolopyridines to give pyrazolopyrimidines that have hitherto been underrepresented in the heterocyclic chemistry literature. The isolation of a linear hydrolysis product supports a mechanistic hypothesis for this rearrangement process. In order to establish a broader access and explore potential biological applications for these medicinal chemistry building blocks, we investigated the scope of the reaction and generated small amine- as well as amide-based libraries through reductive aminations and amide couplings, respectively.
Style APA, Harvard, Vancouver, ISO itp.
29

Rao, V. V. V. N. S. Rama, B. P. V. Lingaiah, G. Venkat Reddy, G. Ezikiel, R. Yadla i P. Shanthan Rao. "Facile synthesis of fluorinated 2-aryl-5,7-bisalkyl pyrazolopyrimidines from arylalkynenitriles". Arkivoc 2006, nr 12 (28.06.2006): 51–57. http://dx.doi.org/10.3998/ark.5550190.0007.c06.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

Rao, R. Nishanth, i Kaushik Chanda. "An assessment study of known pyrazolopyrimidines: Chemical methodology and cellular activity". Bioorganic Chemistry 99 (czerwiec 2020): 103801. http://dx.doi.org/10.1016/j.bioorg.2020.103801.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
31

Bussenius, Joerg, Neel K. Anand, Charles M. Blazey, Owen J. Bowles, Lynne Canne Bannen, Diva S. M. Chan, Baili Chen i in. "Design and evaluation of a series of pyrazolopyrimidines as p70S6K inhibitors". Bioorganic & Medicinal Chemistry Letters 22, nr 6 (marzec 2012): 2283–86. http://dx.doi.org/10.1016/j.bmcl.2012.01.105.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

Shamroukh, Ahmed H., Aymn E. Rashad, Hatem S. Ali i Farouk M. E. Abdel-Megeid. "ChemInform Abstract: Some New Pyrazole and Pyrazolopyrimidines: Synthesis and Antimicrobial Evaluation." ChemInform 44, nr 51 (2.12.2013): no. http://dx.doi.org/10.1002/chin.201351194.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Asati, Vivek, Arjun Anant, Preeti Patel, Kamalpreet Kaur i G. D. Gupta. "Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches". European Journal of Medicinal Chemistry 225 (grudzień 2021): 113781. http://dx.doi.org/10.1016/j.ejmech.2021.113781.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
34

Ahmed, Hatem Abdel Moniem. "A Facile One-pot Synthesis of New Pyrazolopyrimidines and Pyrazolo Pyridines Derivatives". JOURNAL OF ADVANCES IN CHEMISTRY 8, nr 1 (12.03.2014): 1533–38. http://dx.doi.org/10.24297/jac.v8i1.6789.

Pełny tekst źródła
Streszczenie:
A Simple Facile One-pot reaction, novel and efficient rout for the synthesis of substituted pyrazolo [3, 4-d] pyrimidines, and pyrazolo [3, 4-b] pyridines, results from reaction of substituted-5-amino-4-cyanopyrazoles with malononitrile and diethylmalonate respectively. The structures of the products and conceivable mechanisms are discussed. The antibacterial activity of some new synthesized compounds was evaluated and seemed to be significant.
Style APA, Harvard, Vancouver, ISO itp.
35

Rageh, Nasr M. "Acidity Constants of Some Hydroxy Azo Pyrazolopyrimidines in Mixed Aqueous−Organic Solvents". Journal of Chemical & Engineering Data 43, nr 3 (maj 1998): 373–77. http://dx.doi.org/10.1021/je970167g.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

Wu, Tom Y. H., Peter G. Schultz i Sheng Ding. "One-Pot Two-Step Microwave-Assisted Reaction in Constructing 4,5-Disubstituted Pyrazolopyrimidines". Organic Letters 5, nr 20 (październik 2003): 3587–90. http://dx.doi.org/10.1021/ol035226w.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

Rajeswar Rao, V., i V. Ravinder Reddy. "Synthesis of some new types of 3-coumarinyl-substituted pyrazolopyrimidines and imidazothiazoles". Chemistry of Heterocyclic Compounds 44, nr 3 (marzec 2008): 360–65. http://dx.doi.org/10.1007/s10593-008-0053-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

Abdel-Jalil, Raid J., Monther Khanfar, Kayed Abu-Safieh, Samer Al-Gharabli, Mustafa El-Abadelah i Wolfgang Voelter. "An Efficient One-Pot Synthesis of Pyrazolopyrimidines, Intermediates for Potential Phosphodiesterase Inhibitors". Monatshefte f�r Chemie - Chemical Monthly 136, nr 4 (14.01.2005): 619–24. http://dx.doi.org/10.1007/s00706-004-0252-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

Rashad, Aymn E., Mohamed I. Hegab, Randa E. Abdel-Megeid, Nahed Fathalla i Farouk M. E. Abdel-Megeid. "Synthesis and anti-HSV-1 evaluation of some pyrazoles and fused pyrazolopyrimidines". European Journal of Medicinal Chemistry 44, nr 8 (sierpień 2009): 3285–92. http://dx.doi.org/10.1016/j.ejmech.2009.02.012.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
40

Alsaedi, Farghaly i Shaaban. "Synthesis and Antimicrobial Evaluation of Novel Pyrazolopyrimidines Incorporated with Mono- and Diphenylsulfonyl Groups". Molecules 24, nr 21 (5.11.2019): 4009. http://dx.doi.org/10.3390/molecules24214009.

Pełny tekst źródła
Streszczenie:
A novel series of pyrazolo[1,5-a]pyrimidine ring systems containing phenylsulfonyl moiety have been synthesized via the reaction of 2-(phenylsulfonyl)-1-(4-(phenylsulfonyl) phenyl)ethan-1-one, 2-benzenesulfonyl-1-(4-benzenesulfonyl-phenyl)-3-dimethylamino-propenone and 3-(dimethylamino)-1-(4-(phenylsulfonyl)phenyl)prop-2-en-1-one each with various substituted aminoazopyrazole derivatives in one pot reaction strategy. The proposed structure as well as the mechanism of their reactions were discussed and proved with all possible spectral data. The results of antimicrobial activities of the new sulfone derivatives revealed that several derivatives showed activity exceeding the activity of reference drug. Contrary to expectations, we found that derivatives containing one sulfone group are more effective against all bacteria and fungi used than those contain two sulfone groups.
Style APA, Harvard, Vancouver, ISO itp.
41

Voelter, Wolfgang, Raid J. Abdel-Jalil, Monther Khanfar, Samer Al-Gharabli, Mustafa M. El-Abadelah, Klaus Eichele i Muhammad Usman Anwar. "High Throughput Synthesis of Pyrazolopyrimidines via Copper-catalysed Cyclization and X-Ray Study". HETEROCYCLES 65, nr 8 (2005): 1821. http://dx.doi.org/10.3987/com-05-10398.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
42

Azam, Mohammed Afzal, Loganathan Dharanya, Charu Chandrakant Mehta i Sumit Sachdeva. "Synthesis and biological evaluation of some novel pyrazolopyrimidines incorporating a benzothiazole ring system". Acta Pharmaceutica 63, nr 1 (1.03.2013): 19–30. http://dx.doi.org/10.2478/acph-2013-0001.

Pełny tekst źródła
Streszczenie:
In the present study, a series of benzothiazol derivatives 3a-l containing pyrazolo[3,4-d]pyrimidine moiety at the second position were synthesized and characterized by analytical and spectral data. The compounds were tested for their in vitro antimicrobial activity. Compounds 1-(1,3-benzothiazol-2- yl)-3-methyl-4-phenyl-1H-pyrazolo[3,4-d]pyrimidine (3a), 1- (1,3-benzothiazol-2-yl)-4-(4-chlorophenyl)-3-methyl-1H-pyrazolo[ 3,4-d]pyrimidine (3d) and 1-(1,3-benzothiazol-2-yl)- 3-methyl-4-substituted phenyl-1H-pyrazolo[3,4-d]pyrimidines (3h-j) showed significant inhibitory activity against P. aeruginosa whereas compounds 1-(1,3-benzothiazol-2-yl)-4- (2-chlorophenyl)-3-methyl-1H-pyrazolo[3,4-d]pyrimidine (3b), 2-[1-(1,3-benzothiazol-2-yl)-3-methyl-1H-pyrazolo[3,4-d]pyrimidin- 4-yl]phenol (3e), 1-(1,3-benzothiazol-2-yl)-4-(3,4-dimethoxyphenyl)- 3-methyl-1H-pyrazolo[3,4-d]pyrimidine (3h), 4-[1-(1,3-benzothiazol-2-yl)-3-methyl-1H-pyrazolo[3,4-d]pyri midin-4-yl]-N,N-dimethylaniline (3j) and 1-(1,3-benzothiazol- 2-yl)-3-methyl-4-[2-phenylvinyl]-1H-pyrazolo[3,4-d]pyrimidine (3k) were found to be active against C. albicans. Some of these synthesized compounds were evaluated for their in vivo acute toxicity, analgesic, anti-inflammatory, and ulcerogenic actions. The tested compound 4-[1-(1,3-benzothiazol- 2-yl)-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl]-N, N-dimethylaniline (3j) exhibited maximum analgesic and anti-inflammatory activities. Compounds 1-(1,3-benzothiazol- -2-yl)-3-methyl-4-(3-nitrophenyl)-1H-pyrazolo[3,4-d]pyrimidine (3i) and 3j showed a significant gastrointestinal protection compared to the standard drug diclofenac sodium.
Style APA, Harvard, Vancouver, ISO itp.
43

Qu, Chunrong, Mingmin Ding, Yingmin Zhu, Yungang Lu, Juan Du, Melissa Miller, Jinbin Tian i in. "Pyrazolopyrimidines as Potent Stimulators for Transient Receptor Potential Canonical 3/6/7 Channels". Journal of Medicinal Chemistry 60, nr 11 (28.04.2017): 4680–92. http://dx.doi.org/10.1021/acs.jmedchem.7b00304.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

Hameed P, Shahul, Praveena Manjrekar, Murugan Chinnapattu, Vaishali Humnabadkar, Gajanan Shanbhag, Chaitanyakumar Kedari, Naina Vinay Mudugal i in. "Pyrazolopyrimidines Establish MurC as a Vulnerable Target in Pseudomonas aeruginosa and Escherichia coli". ACS Chemical Biology 9, nr 10 (5.08.2014): 2274–82. http://dx.doi.org/10.1021/cb500360c.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
45

Liu, Xu, Alvin Kung, Brock Malinoski, G. K. Surya Prakash i Chao Zhang. "Development of Alkyne-Containing Pyrazolopyrimidines To Overcome Drug Resistance of Bcr-Abl Kinase". Journal of Medicinal Chemistry 58, nr 23 (20.11.2015): 9228–37. http://dx.doi.org/10.1021/acs.jmedchem.5b01125.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
46

Singsardar, Mukta, Rajib Sarkar, Koushik Majhi, Subrata Sinha i Alakananda Hajra. "Brønsted Acidic Ionic Liquid-Catalyzed Regioselective Synthesis of Pyrazolopyrimidines and Their Photophysical Properties". ChemistrySelect 3, nr 5 (5.02.2018): 1404–10. http://dx.doi.org/10.1002/slct.201702767.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
47

Alcaro, Stefano, Anna Artese, Maurizio Botta, Alessandra T Zizzari, Francisco Orallo, Francesco Ortuso, Silvia Schenone, Chiara Brullo i Matilde Yáñez. "Hit Identification and Biological Evaluation of Anticancer Pyrazolopyrimidines Endowed with Anti-inflammatory Activity". ChemMedChem 5, nr 8 (16.06.2010): 1242–46. http://dx.doi.org/10.1002/cmdc.201000165.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
48

Jia, Cong-Cong, Wang Chen, Zi-Li Feng i Zhao-Peng Liu. "Recent developments of RET protein kinase inhibitors with diverse scaffolds as hinge binders". Future Medicinal Chemistry 13, nr 1 (styczeń 2021): 45–62. http://dx.doi.org/10.4155/fmc-2020-0170.

Pełny tekst źródła
Streszczenie:
RET is a proto-oncogene encoding a receptor tyrosine kinase. RET regulates key aspects of cellular proliferation, differentiation and survival. The activation of RET via gene fusions or point mutations is closely related to lung, thyroid and other cancers. This review summarizes the developments of a diversity of small molecule RET protein kinase inhibitors in the past 10 years. These RET inhibitors are classified according to their hinge binder chemotypes as: pyrimidines, including the pyrazolopyrimidines, pyrimidine oxazines, quinazolines, 4-aminopyrimidines and 4-aminopyridines; indolinones; 5-aminopyrazole-4-carboxamides; 3-trifluoromethylanilines; imidazopyridines, imidazopyridazines and pyrazopyridines; nicotinonitriles; pyridones and 1,2,4-triazoles. In each section, the biological activities of the inhibitors, their structure–activity relationships and possible binding modes with the RET kinase are introduced.
Style APA, Harvard, Vancouver, ISO itp.
49

Li, Wen, Jinyang Zhang, Min Wang, Ru Dong, Xin Zhou, Xin Zheng i Liping Sun. "Pyrimidine-fused Dinitrogenous Penta-heterocycles as a Privileged Scaffold for Anti-Cancer Drug Discovery". Current Topics in Medicinal Chemistry 22, nr 4 (luty 2022): 284–304. http://dx.doi.org/10.2174/1568026622666220111143949.

Pełny tekst źródła
Streszczenie:
Abstract: Pyrimidine-fused derivatives that are the inextricable part of DNA and RNA play a key role in the normal life cycle of cells. Pyrimidine-fused dinitrogenous penta-heterocycles, including pyrazolopyrimidines and imidazopyrimidines are a special class of pyrimidine-fused compounds contributing to an important portion in anti-cancer drug discovery, which has been discovered as the core structure for promising anti-cancer agents used in the clinic or clinical evaluations. Pyrimidine-fused dinitrogenous penta-heterocycles have become one privileged scaffold for anti-cancer drug discovery. This review consists of the recent progress of pyrimidine-fused dinitrogenous penta-heterocycles as anti-cancer agents and their synthetic strategies. In addition, this review also summa-rizes some key structure-activity relationships (SARs) of pyrimidine-fused dinitrogenous penta-heterocycle derivatives as anti-cancer agents.
Style APA, Harvard, Vancouver, ISO itp.
50

Akhramez, Soufiane, Asmaa Oumessaoud, Achraf Hibot, Soumaya Talbi, Salha Hamri, El Mostafa Ketatni, Hajiba Ouchetto i in. "Synthesis of pyrazolo-enaminones, bipyrazoles and pyrazolopyrimidines and evaluation of antioxidant and antimicrobial properties". Arabian Journal of Chemistry 15, nr 1 (styczeń 2022): 103527. http://dx.doi.org/10.1016/j.arabjc.2021.103527.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii